Insider Transactions in Q2 2021 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.61%
|
$116,620
$70.65 P/Share
|
|
Jun 07
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
94,378
-1.79%
|
$6,606,460
$70.7 P/Share
|
|
Jun 07
2021
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
94,378
+1.19%
|
$1,698,804
$18.81 P/Share
|
|
Jun 04
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-0.98%
|
$640,000
$64.58 P/Share
|
|
Jun 02
2021
|
Douglas G. Cole Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+28.02%
|
-
|
|
Jun 02
2021
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+28.02%
|
-
|
|
Jun 02
2021
|
Jay T Flatley Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,074
+0.62%
|
-
|
|
Jun 02
2021
|
Peter S Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+28.02%
|
-
|
|
Jun 02
2021
|
Robert Nelsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+14.3%
|
-
|
|
Jun 02
2021
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+1.5%
|
-
|
|
Jun 02
2021
|
David P Schenkein Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+28.02%
|
-
|
|
Jun 02
2021
|
Marc Tessier Lavigne Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+0.08%
|
-
|
|
Jun 01
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,333
-0.21%
|
$1,136,646
$62.33 P/Share
|
|
Jun 01
2021
|
Douglas G. Cole Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,253
+50.0%
|
-
|
|
Jun 01
2021
|
Jennifer E. Cook Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,253
+50.0%
|
-
|
|
Jun 01
2021
|
Jay T Flatley Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
3,253
+0.98%
|
-
|
|
Jun 01
2021
|
Peter S Klein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,253
+50.0%
|
-
|
|
Jun 01
2021
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,253
+50.0%
|
-
|
|
Jun 01
2021
|
Robert Nelsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,253
+23.9%
|
-
|
|
May 26
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.41%
|
$108,290
$65.83 P/Share
|
|
May 24
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
8,806
-0.35%
|
$528,360
$60.02 P/Share
|
|
May 21
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
37,957
-1.47%
|
$2,277,420
$60.13 P/Share
|
|
May 12
2021
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
2,537
+26.31%
|
-
|
|
May 12
2021
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-4.92%
|
-
|
|
May 04
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-0.64%
|
$560,000
$56.13 P/Share
|
|
May 03
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,333
-0.27%
|
$1,081,647
$59.16 P/Share
|
|
May 03
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
3,237
-0.06%
|
$194,220
$60.64 P/Share
|
|
Apr 28
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.41%
|
$101,626
$61.93 P/Share
|
|
Apr 05
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-0.63%
|
$560,000
$56.5 P/Share
|
|
Apr 01
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,334
-0.27%
|
$1,026,704
$56.57 P/Share
|
|
Apr 01
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
50,000
-0.63%
|
$2,800,000
$56.7 P/Share
|